You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ELOXATIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Eloxatin patents expire, and what generic alternatives are available?

Eloxatin is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in ELOXATIN is oxaliplatin. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the oxaliplatin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Eloxatin

A generic version of ELOXATIN was approved as oxaliplatin by HOSPIRA WORLDWIDE on August 7th, 2009.

  Try a Trial

Drug patent expirations by year for ELOXATIN
Recent Clinical Trials for ELOXATIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 1
Kimberly PerezPhase 2
NovartisPhase 2

See all ELOXATIN clinical trials

Paragraph IV (Patent) Challenges for ELOXATIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ELOXATIN Injection oxaliplatin 5 mg/mL, 40 mL vials 021759 1 2007-07-16
ELOXATIN Injection oxaliplatin 5 mg/mL, 10 mL and 20 mL vials 021759 11 2007-02-09

US Patents and Regulatory Information for ELOXATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021492-001 Aug 9, 2002 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-002 Jan 31, 2005 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-001 Jan 31, 2005 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021492-002 Aug 9, 2002 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-003 Nov 17, 2006 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ELOXATIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-003 Nov 17, 2006 ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-002 Jan 31, 2005 ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021492-001 Aug 9, 2002 ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021492-002 Aug 9, 2002 ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-002 Jan 31, 2005 ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-003 Nov 17, 2006 ⤷  Try a Trial ⤷  Try a Trial
Sanofi Aventis Us ELOXATIN oxaliplatin INJECTABLE;INTRAVENOUS 021759-001 Jan 31, 2005 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ELOXATIN

See the table below for patents covering ELOXATIN around the world.

Country Patent Number Title Estimated Expiration
Australia 2989695 ⤷  Try a Trial
Brazil 9508554 ⤷  Try a Trial
Japan H06329692 OPTICALLY HIGH-PURITY CIS-OXALATE (TRANS-L-1,2-CYCLOHEXANEDIAMINE) PLATINUM (II) COMPLEX AND ITS PRODUCTION ⤷  Try a Trial
Japan H05194332 PRODUCTION OF PLATINUM COMPOUND ⤷  Try a Trial
Spain 2167328 ⤷  Try a Trial
Russian Federation 2148400 PHARMACEUTICALLY STABLE PREPARATION OF OXALYPLATINUM ⤷  Try a Trial
Czech Republic 286714 Pharmaceutically stable preparation based on oxaliplatinum ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.